Solventum raises annual profit forecast on strength in surgical equipment

Market Closed – Nyse			5-day change	1st Jan Change
71.52 ^USD	+7.91%		+3.59%	+8.27%

Published on 11/06/2025
at 05:52 pm EST

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

Nov. 07	Wells Fargo Adjusts Solventum Price Target to $72 From $82, Maintains Equal Weight Rating	MT
Nov. 07	Jefferies Adjusts Price Target on Solventum to $75 From $80, Maintains Hold Rating	MT
Nov. 07	Piper Sandler Adjusts Price Target on Solventum to $98 From $94, Maintains Overweight Rating	MT
Nov. 06	Solventum raises annual profit forecast on strength in surgical equipment	RE
Nov. 06	Solventum Corporation, Q3 2025 Earnings Call, Nov 06, 2025
Nov. 06	Healthcare products firm Solventum Q3 sales beat estimates, partly driven by dental segment growth	RE
Nov. 06	Solventum Q3 Adjusted Earnings Fall, Revenue Rises; 2025 EPS Guidance Revised	MT
Nov. 06	GUIDANCE: (SOLV) Solventum Now Expects 2025 Adjusted EPS $5.98-$6.08, vs. FactSet Est of $5.95	MT
Nov. 06	Earnings Flash (SOLV) Solventum Corporation Reports Q3 Revenue $2.10B, vs. FactSet Est of $2.06B	MT
Nov. 06	Earnings Flash (SOLV) Solventum Corporation Posts Q3 Adjusted EPS $1.50 per Share, vs. FactSet Est of $1.43	MT
Nov. 06	Solventum Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Nov. 06	Solventum Corporation Increases Earnings Guidance for 2025	CI
Oct. 28	Thermo Fisher nears $10 billion takeover of Clario, FT reports	RE
Oct. 22	Thermo Fisher beats third-quarter estimates on strong demand for lab tools	RE
Oct. 21	Solventum Appoints Heather Knight as Chief Commercial Officer	MT
Oct. 21	Solventum appoints Heather Knight as Chief Commercial Officer	RE
Oct. 21	Solventum Announces Executive Changes	CI
Oct. 01	Goldman Sachs Adjusts Price Target on Solventum to $72 From $73, Maintains Sell Rating	MT
Sep. 11	Jefferies Initiates Solventum at Hold With $80 Price Target	MT
Sep. 09	Solventum Corporation Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 10:45 AM
Sep. 08	Solventum Prices Upsized Tender Offers for Senior Notes	MT
Sep. 08	Solventum announces pricing of its upsized $2 bln note tender offers	RE
Sep. 08	Solventum Corporation Announces Pricing of its Upsized $2 Billion Note Tender Offers	CI
Sep. 08	Solventum Announces Early Tender Results and Upsizing of Its Note Tender Offers	CI
Sep. 08	Solventum Reports Early Results of Tender Offers	MT

Duration

Period

SOLV: Dynamic Chart

Solventum Corporation specializes in the marketing of tools used in the medical field. Net sales break down by family of products as follows:

– medical instruments and accessories (56.2%): for wound care, sterilization, surgery, etc.;

– medical information systems (15.8%): including software solutions for documentation, billing, coding, data visualization, etc. in hospital environments;

– dental and orthodontic instruments and accessories (15.7%): for dental care and restoration;

– purification and filtration instruments (11.6%): used in the medical, bio-pharmaceutical, agri-food and other sectors;

– other (0.7%).

The United States accounts for 57.5% of net sales.

More about the company